Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willy E Peetermans

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Acta Clinica Belgica|February 1, 2020
The impact of childhood 13-valent pneumococcal conjugate vaccination on overall invasive pneumococcal disease, including the oldest oldLiesbet Henckaerts, Stefanie Desmet, Nele Schalck, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2011
Divergent intentions to use antibiotic guidelines: a theory of planned behavior surveyPieter-Jan Cortoos, Bert H J Schreurs, Willy E Peetermans, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2008
Clinical and echocardiographic risk factors for embolism and mortality in infective endocarditisEvelyn E Hill, Paul Herijgers, Piet Claus, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2020
Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood samplingMatthias Gijsen, Johan Maertens, Katrien Lagrou, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2005
Fcgamma-receptor IIA genotype and invasive pneumococcal infectionLeen Moens, Erna Van Hoeyveld, Jan Verhaegen, et al.
The American Journal of Cardiology|April 9, 2008
Management of prosthetic valve infective endocarditisEvelyn E Hill, Marie-Christine Herregods, Steven Vanderschueren, et al.
Acta Clinica Belgica|July 8, 2016
Incidence and risk factors of fever in a contemporary cohort of HIV-patients with good access to antiretroviral therapyPaul De Munter, Inge Derdelinckx, Willy E Peetermans, et al.
Scandinavian Journal of Infectious Diseases|November 2, 2012
Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumoniaPieter-Jan Cortoos, Christa Gilissen, Gert Laekeman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Use of semiautomatic treatment advice to improve compliance with Infectious Diseases Society of America guidelines for treatment of intravascular catheter-related infection: a before-after studyBart J A Rijnders, Stefaan J Vandecasteele, Eric Van Wijngaerden, et al.
Microbes and Infection|January 2, 2007
Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal diseaseLeen Moens, Jan Verhaegen, Marie Pierik, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Acta Clinica Belgica|February 1, 2020
The impact of childhood 13-valent pneumococcal conjugate vaccination on overall invasive pneumococcal disease, including the oldest oldLiesbet Henckaerts, Stefanie Desmet, Nele Schalck, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2011
Divergent intentions to use antibiotic guidelines: a theory of planned behavior surveyPieter-Jan Cortoos, Bert H J Schreurs, Willy E Peetermans, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2008
Clinical and echocardiographic risk factors for embolism and mortality in infective endocarditisEvelyn E Hill, Paul Herijgers, Piet Claus, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2020
Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood samplingMatthias Gijsen, Johan Maertens, Katrien Lagrou, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2005
Fcgamma-receptor IIA genotype and invasive pneumococcal infectionLeen Moens, Erna Van Hoeyveld, Jan Verhaegen, et al.
The American Journal of Cardiology|April 9, 2008
Management of prosthetic valve infective endocarditisEvelyn E Hill, Marie-Christine Herregods, Steven Vanderschueren, et al.
Acta Clinica Belgica|July 8, 2016
Incidence and risk factors of fever in a contemporary cohort of HIV-patients with good access to antiretroviral therapyPaul De Munter, Inge Derdelinckx, Willy E Peetermans, et al.
Scandinavian Journal of Infectious Diseases|November 2, 2012
Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumoniaPieter-Jan Cortoos, Christa Gilissen, Gert Laekeman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Use of semiautomatic treatment advice to improve compliance with Infectious Diseases Society of America guidelines for treatment of intravascular catheter-related infection: a before-after studyBart J A Rijnders, Stefaan J Vandecasteele, Eric Van Wijngaerden, et al.
Microbes and Infection|January 2, 2007
Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal diseaseLeen Moens, Jan Verhaegen, Marie Pierik, et al.
Pageof 9